Paper39083045
Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor.
Kooiker K and 15 others. J Gen Physiol, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of a novel regulatory light chain-dependent cardiac myosin inhibitor. Papers, record 39083045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39083045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Contraction | Major topic |
| Animals | |
| Rats | |
| Myosin Light Chains | |
| Cattle | |
| Myofibrils | |
| Cardiac Myosins | |
| Rats, Sprague-Dawley | |
| Male | |
| Calcium |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DE-AC02-06CH11357 | U.S. Department of Energy | PubMed | PubMed | ||
| R01 HL157169 | NHLBI NIH HHS | United States | R01HL157169 | PubMed and NIH | NIH RePORTER |
| P30 AR074990 | NIAMS NIH HHS | United States | P30AR074990 | PubMed and NIH | NIH RePORTER |
| K08 HL128826 | NHLBI NIH HHS | United States | K08HL128826 | PubMed and NIH | NIH RePORTER |
| R01 HL128368 | NHLBI NIH HHS | United States | R01HL128368 | PubMed and NIH | NIH RePORTER |
| MyoKon 11456 | Bristol Myers Squibb | PubMed | PubMed | ||
| T32 EB032787 | NIBIB NIH HHS | United States | T32EB032787 | PubMed | NIH RePORTER |
| R01 HL128368 | NIH HHS | United States | R01HL128368 | PubMed and NIH | NIH RePORTER |
| P30 GM138395 | NIGMS NIH HHS | United States | P30GM138395 | PubMed and NIH | NIH RePORTER |
| P30AR074990 | University of Washington | P30AR074990 | PubMed and NIH | NIH RePORTER | |
| RM1GM131981 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 39136654 | Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy. | https://conductscience.org/library/papers/39136654 |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23629510 | Contractility and kinetics of human fetal and human adult skeletal muscle. | J Physiol | 2013 | https://conductscience.org/library/papers/23629510 | PubMed |
| 2 | 4254541 | The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. | J Biol Chem | 1971 | https://conductscience.org/library/papers/4254541 | PubMed |
| 3 | 34117120 | Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34117120 | PubMed |
| 4 | 7121269 | Purification of muscle actin. | Methods Enzymol | 1982 | https://conductscience.org/library/papers/7121269 | PubMed |
| 5 | 26912705 | A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice. | Science | 2016 | https://conductscience.org/library/papers/26912705 | PubMed |
| 6 | 20123786 | Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development. | J Physiol | 2010 | https://conductscience.org/library/papers/20123786 | PubMed |
| 7 | 38494592 | Mechanistic basis for rescuing hypertrophic cardiomyopathy with myosin regulatory light chain phosphorylation. | Cytoskeleton (Hoboken) | 2024 | https://conductscience.org/library/papers/38494592 | PubMed |
| 8 | 33449850 | Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue. | Am J Physiol Heart Circ Physiol | 2021 | https://conductscience.org/library/papers/33449850 | PubMed |
| 9 | 34365814 | The Super-Relaxed State and Length Dependent Activation in Porcine Myocardium. | Circ Res | 2021 | https://conductscience.org/library/papers/34365814 | PubMed |
| 10 | 6214692 | Preparation of myosin and its subfragments from rabbit skeletal muscle. | Methods Enzymol | 1982 | https://conductscience.org/library/papers/6214692 | PubMed |
| 11 | 23454346 | Structural and functional consequences of cardiac troponin C L57Q and I61Q Ca(2+)-desensitizing variants. | Arch Biochem Biophys | 2013 | https://conductscience.org/library/papers/23454346 | PubMed |
| 12 | 9147336 | Active and passive forces of isolated myofibrils from cardiac and fast skeletal muscle of the frog. | J Physiol | 1997 | https://conductscience.org/library/papers/9147336 | PubMed |
| 13 | 27114035 | A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy. | Cell | 2016 | https://conductscience.org/library/papers/27114035 | PubMed |
| 14 | 30706179 | Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains. | Pflugers Arch | 2019 | https://conductscience.org/library/papers/30706179 | PubMed |
| 15 | 28912181 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. | Circ Res | 2017 | https://conductscience.org/library/papers/28912181 | PubMed |
| 16 | 34606259 | Discovery of Aficamten (CK-274), a Next-Generation Cardiac Myosin Inhibitor for the Treatment of Hypertrophic Cardiomyopathy. | J Med Chem | 2021 | https://conductscience.org/library/papers/34606259 | PubMed |
| 17 | 22874472 | Hypertrophic cardiomyopathy. | Lancet | 2013 | https://conductscience.org/library/papers/22874472 | PubMed |
| 18 | 35802255 | Mavacamten: First Approval. | Drugs | 2022 | https://conductscience.org/library/papers/35802255 | PubMed |
| 19 | 24312057 | Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C. | Front Physiol | 2013 | https://conductscience.org/library/papers/24312057 | PubMed |
| 20 | 30767072 | Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations. | Pflugers Arch | 2019 | https://conductscience.org/library/papers/30767072 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42770301 | Mechanistic diversity within RLC-dependent myosin ATPase inhibitors differentiates EDG-7500, a diastolic-selective cardiac sarcomere modulator. | JCI Insight | 2026 | https://conductscience.org/library/papers/42770301 | PubMed |
| 39136654 | Novel cardiac myosin inhibitor for hypertrophic cardiomyopathy. | J Gen Physiol | 2024 | https://conductscience.org/library/papers/39136654 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39083045
GET https://conductscience.org/api/papers/v1/39083045/references?page=2